Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
Agid
Y
Y
Destée
A
A
Durif
F
F
Montastruc
J L
JL
Pollak
P
P
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001577:Benzophenones / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D009596:Nitrophenols; D010300:Parkinson Disease / Q000188:drug therapy*; D000077867:Tolcapone
D000978:Antiparkinson Agents; D001577:Benzophenones; D009596:Nitrophenols; D001971:Bromocriptine; D007980:Levodopa; D000077867:Tolcapone